AbbVie, Merz's $54.4 Million Settlement in Namenda Suit Approved

摘要

AbbVie Inc. and Merz Holding Gmbh & Co. Affiliate received final approval for a $54.4 million settlement of a lawsuit that claimed the pharmaceutical companies conspired to block generic competition for the Alzheimer's drug Namenda.